346.50
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SYK?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$346.67
Offen:
$346.17
24-Stunden-Volumen:
1.35M
Relative Volume:
0.86
Marktkapitalisierung:
$134.90B
Einnahmen:
$22.60B
Nettoeinkommen (Verlust:
$2.99B
KGV:
44.65
EPS:
7.76
Netto-Cashflow:
$3.49B
1W Leistung:
-0.54%
1M Leistung:
-7.23%
6M Leistung:
-3.68%
1J Leistung:
+3.12%
Stryker Corp Stock (SYK) Company Profile
Firmenname
Stryker Corp
Sektor
Branche
Telefon
(269) 385-2600
Adresse
1941 STRYKER WAY, PORTAGE, MI
Vergleichen Sie SYK mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-26 | Fortgesetzt | Citigroup | Buy |
2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2024-09-10 | Eingeleitet | Wolfe Research | Outperform |
2024-05-30 | Eingeleitet | Goldman | Neutral |
2024-05-22 | Hochstufung | Needham | Hold → Buy |
2024-01-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
2023-10-20 | Eingeleitet | ROTH MKM | Buy |
2023-09-05 | Hochstufung | BofA Securities | Neutral → Buy |
2023-03-29 | Eingeleitet | UBS | Neutral |
2023-01-25 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2022-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
2022-10-18 | Eingeleitet | Barclays | Overweight |
2022-10-12 | Eingeleitet | Jefferies | Buy |
2022-07-28 | Hochstufung | Edward Jones | Hold → Buy |
2022-07-21 | Herabstufung | Deutsche Bank | Buy → Hold |
2022-07-11 | Herabstufung | BofA Securities | Buy → Neutral |
2022-04-13 | Eingeleitet | Truist | Hold |
2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
2022-03-15 | Fortgesetzt | Evercore ISI | Outperform |
2022-03-02 | Fortgesetzt | BofA Securities | Buy |
2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
2021-12-07 | Eingeleitet | Loop Capital | Buy |
2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
2021-07-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
2021-06-01 | Hochstufung | Evercore ISI | In-line → Outperform |
2021-05-25 | Eingeleitet | Barclays | Underweight |
2020-10-06 | Eingeleitet | Northland Capital | Market Perform |
2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
2020-04-13 | Herabstufung | Barclays | Equal Weight → Underweight |
2020-04-01 | Herabstufung | Goldman | Buy → Sell |
2020-03-05 | Eingeleitet | Citigroup | Buy |
2020-02-13 | Eingeleitet | Goldman | Buy |
2020-01-08 | Eingeleitet | SunTrust | Hold |
2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
2019-12-30 | Bestätigt | BTIG Research | Buy |
2019-11-05 | Herabstufung | Barclays | Overweight → Equal Weight |
2019-10-30 | Bestätigt | BofA/Merrill | Buy |
2019-07-02 | Herabstufung | Evercore ISI | Outperform → In-line |
2019-01-30 | Bestätigt | Canaccord Genuity | Buy |
2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
2019-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
2018-10-16 | Eingeleitet | Barclays | Overweight |
2018-08-16 | Eingeleitet | BTIG Research | Buy |
2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
2018-04-27 | Bestätigt | Stifel | Buy |
Alle ansehen
Stryker Corp Aktie (SYK) Neueste Nachrichten
Here's What To Expect From Stryker Corporation's Next Earnings Report - Barchart.com
Fed. Circ. Won't Revive Stryker Unit's Antiseptic Patents - Law360
Federal Circuit Axes Stryker Unit’s Sterilized Wipe Patents - Bloomberg Law News
Stryker Corporation (SYK): A Bull Case Theory - Yahoo Finance
The Zacks Analyst Blog Bank of America, Chevron, Stryker, Value Line and Sypris - Yahoo Finance
Stryker (SYK): BTIG Analyst Revises Price Target Amid MedTech Ou - GuruFocus
Top Analyst Reports for Bank of America, Chevron & Stryker - Yahoo Finance
Meritage Homes, TopBuild, Installed Building Products, Champion Homes, and Stryker Shares Plummet, What You Need To Know - Yahoo Finance
Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights - GlobeNewswire Inc.
What Does the Market Think About Stryker? - Benzinga
Teledyne Technologies Awarded Four-Year, $74 Million US Army Contract to Upgrade Stryker Sensors - MarketScreener
Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Stryker (SYK): Buy, Sell, Or Hold Post Q4 Earnings? - Barchart.com
Stryker to announce financial results for its first quarter of fiscal year 2025 - MarketScreener
Mark Your Calendar: Stryker's Q1 2025 Earnings Release Coming May 1 - Stock Titan
Stryker Corporation : INVESTOR ALERTPATIENT SAFETY TECHNOLOGIES, INC. - MarketScreener
Activist shareholder renews push for Stryker to reveal political contributions - Crain's Grand Rapids Business
Stryker, Boston Scientific down as new tariffs impact medtech industry - Seeking Alpha
Pictet Asset Management Holding SA Cuts Stock Position in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker completes sale of U.S. spinal implants business - Ortho Spine News
Evercore ISI Adjusts Stryker Price Target to $400 From $410, Maintains Outperform Rating - MarketScreener
Stryker (SYK): Company Profile, Stock Price, News, Rankings - Fortune
Stryker : 2024 Comprehensive Report - MarketScreener
Stryker Closes Sale of US Spinal Implants Unit to Vascogliosi Brothers - MarketScreener
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC - Yahoo Finance
Stryker sells US spinal implants business to VB Spine - Investing.com
Stryker Completes Sale Of U.S. Spinal Implants Business - MarketScreener
Stryker Co. (NYSE:SYK) Shares Sold by Franklin Resources Inc. - MarketBeat
Major Strategic Shift: Stryker Sells Spinal Unit While Keeping Key Tech Rights - Stock Titan
Stryker Corporation (NYSE:SYK): One of the Best Robotics Stocks to Buy According to Billionaires - Insider Monkey
Stocks With Rising Relative Strength: Stryker - MSN
California Public Employees Retirement System Raises Stake in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker Corporation (SYK): Jim Cramer Sees Big Gains Despite Tariff Worries - Insider Monkey
Ex-Dividend Reminder: Stryker, Innovative Industrial Properties and Apple Hospitality REIT - Nasdaq
Jim Cramer: Stryker Is A 'Good' Company, Says He Likes This Utilities Stock - Benzinga
Stryker Options Trading: A Deep Dive into Market Sentiment - Benzinga
Stryker increases pay for top execs, reports slightly lower wage for median employee - Medical Design & Outsourcing
Stryker announces intention to nominate Manny Maceda to board of directors - Quantisnow
Stryker nominates new board member - Investing.com
Stryker nominates new board member By Investing.com - Investing.com Canada
Is It Smart To Buy Stryker Corporation (NYSE:SYK) Before It Goes Ex-Dividend? - Yahoo Finance
Global Transformation Expert and Bain Chairman Joins Stryker's Board - Stock Titan
Stryker announces Annual Meeting of Shareholders - The Globe and Mail
Here's How Much $1000 Invested In Stryker 5 Years Ago Would Be Worth Today - Benzinga
Stryker Makes Shareholder Meeting Accessible: Virtual Format Opens Doors to All Investors - Stock Titan
What's Driving the Market Sentiment Around Stryker? - Benzinga
Breaking Down Stryker: 13 Analysts Share Their Views - Benzinga
Needham maintains Stryker stock Buy rating, $442 target - Investing.com
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec - Yahoo Finance
New Jersey Rep. Thomas Kean Sold Over $17K Worth of Stryker Stock: Here's What You Should Know - Benzinga
Stryker : 2024 Comprehensive Report Factsheet -March 17, 2025 at 08:10 am EDT - Marketscreener.com
Finanzdaten der Stryker Corp-Aktie (SYK)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):